Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sun-Young Han

Showing results (91-100 of 95) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 95 results.
Journal of Medicinal Chemistry|April 6, 2010
5,5'-substituted indirubin-3'-oxime derivatives as potent cyclin-dependent kinase inhibitors with anticancer activitySoo-Jeong Choi, Jung-Eun Lee, Soon-Young Jeong, et al.
Neurochemistry International|January 10, 2013
Neuroprotective effects of valproic acid against hemin toxicity: possible involvement of the down-regulation of heme oxygenase-1 by regulating ubiquitin-proteasomal pathwayKyoung Ja Kwon, Jung Nam Kim, Min Kyeong Kim, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2012
Synthesis and structure-activity relationship of aminopyridines with substituted benzoxazoles as c-Met kinase inhibitorsJongkook Lee, Sun-Young Han, Heejung Jung, et al.
Frontiers in Immunology|March 20, 2023
COVID-19 spike polypeptide vaccine reduces the pathogenesis and viral infection in a mouse model of SARS-CoV-2Yasmin Hisham, Sun-Min Seo, Sinae Kim, et al.
European Journal of Medicinal Chemistry|April 10, 2020
Discovery of orally active indirubin-3'-oxime derivatives as potent type 1 FLT3 inhibitors for acute myeloid leukemiaPyeonghwa Jeong, Yeongyu Moon, Je-Heon Lee, et al.
Pageof 10

Showing results (91-100 of 95) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 95 results.
Journal of Medicinal Chemistry|April 6, 2010
5,5'-substituted indirubin-3'-oxime derivatives as potent cyclin-dependent kinase inhibitors with anticancer activitySoo-Jeong Choi, Jung-Eun Lee, Soon-Young Jeong, et al.
Neurochemistry International|January 10, 2013
Neuroprotective effects of valproic acid against hemin toxicity: possible involvement of the down-regulation of heme oxygenase-1 by regulating ubiquitin-proteasomal pathwayKyoung Ja Kwon, Jung Nam Kim, Min Kyeong Kim, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2012
Synthesis and structure-activity relationship of aminopyridines with substituted benzoxazoles as c-Met kinase inhibitorsJongkook Lee, Sun-Young Han, Heejung Jung, et al.
Frontiers in Immunology|March 20, 2023
COVID-19 spike polypeptide vaccine reduces the pathogenesis and viral infection in a mouse model of SARS-CoV-2Yasmin Hisham, Sun-Min Seo, Sinae Kim, et al.
European Journal of Medicinal Chemistry|April 10, 2020
Discovery of orally active indirubin-3'-oxime derivatives as potent type 1 FLT3 inhibitors for acute myeloid leukemiaPyeonghwa Jeong, Yeongyu Moon, Je-Heon Lee, et al.
Pageof 10